Human Eotaxin-2 Recombinant
$70.00 – $2,700.00
accession | O00175 |
Source | Optimized DNA sequence encoding HumanEotaxin-2 mature chain was expressed in Escherichia Coli. |
Molecular weight | Native human Eotaxin-2 has a calculated molecular mass of approximately 9 kDa. Recombinant Eotaxin-2 is a monomer protein consisting of 79 amino acid residue subunits, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. |
Purity | >97%, as determined by SDS-PAGE and HPLC |
Biological Activity | Activity was determined by the ability to induce chemotaxis of purified eosinophils at concentrations ranging between-100 ng/ml. |
Protein Sequence | MAGLMTIVTS LLFLGVCAHH IIPTGSVVIP SPCCMFFVSK RIPENRVVSY QLSSRSTCLK AGVIFTTKKG QQFCGDPKQE WVQRYMKNLD AKQKKASPRA RAVA VKGPVQ RYPGNQTTC |
Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg(1EU/µg). |
Presentation | Recombinant Eotaxin-2 waslyophilzed from.2μm filtered concentrated (1.0mg/ml) solution inmM NaCl,mM PB, pH7.0. |
Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than.1 mg/mL. This solution can then be diluted into other buffers. |
Storage | The lyophilized protein is stable for at least years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at° -° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
Usage | This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
Interactor | P51677 |
Biological Process | Chemotaxis |
Biological Process | Inflammatory-response |
Molecular function | Cytokine |